Related references
Note: Only part of the references are listed.Bioluminescence Imaging Correlates with Tumor Serum Marker, Organ Weights, Histology, and Human DNA Levels during Treatment of Orthotopic Tumor Xenografts with Antibodies
Thomas Poeschinger et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Guidelines for the diagnosis and management of multiple myeloma 2011
Jennifer M. Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
CD8 T Cells Activated in Distinct Lymphoid Organs Differentially Express Adhesion Proteins and Coexpress Multiple Chemokine Receptors
Andrew R. Ferguson et al.
JOURNAL OF IMMUNOLOGY (2010)
The evolution and impact of therapy in multiple myeloma
Jacob P. Laubach et al.
MEDICAL ONCOLOGY (2010)
Adhesion molecules-The lifelines of multiple myeloma cells
Ben-Zion Katz
SEMINARS IN CANCER BIOLOGY (2010)
A murine model of myeloma that allows genetic manipulation of the host microenvironment
Jessica A. Fowler et al.
DISEASE MODELS & MECHANISMS (2009)
The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models
S. Deleu et al.
LEUKEMIA (2009)
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect
Henk Rozemuller et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals
Clara P. W. Klerk et al.
BIOTECHNIQUES (2007)
Chemokines in multiple myeloma
Rohit Aggarwal et al.
EXPERIMENTAL HEMATOLOGY (2006)
Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor
MB Mokyr et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
A Beilhack et al.
BLOOD (2005)
Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice
SS Park et al.
CANCER RESEARCH (2005)
CXCR3-binding chemokines in multiple myeloma
A Pellegrino et al.
CANCER LETTERS (2004)
Integrin α4β1 involvement in stromal cell-derived factor-1α-promoted myeloma cell transendothelial migration and adhesion:: role of cAMP and the actin cytoskeleton in adhesion
M Parmo-Cabañas et al.
EXPERIMENTAL CELL RESEARCH (2004)
Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity
VM Jovasevic et al.
JOURNAL OF IMMUNOLOGY (2004)
The SCID-rab model:: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
K Yata et al.
LEUKEMIA (2004)
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1,-2 and-3
IV Broek et al.
BRITISH JOURNAL OF CANCER (2003)
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
M Edinger et al.
BLOOD (2003)
Multiple myeloma: Evolving genetic events and host interactions
WM Kuehl et al.
NATURE REVIEWS CANCER (2002)
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models
M Mittelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
